stoxline Quote Chart Rank Option Currency Glossary
  
Bruker Corporation (BRKR)
84.67  0.93 (1.11%)    02-23 16:00
Open: 84.13
High: 84.875
Volume: 789,147
  
Pre. Close: 83.74
Low: 83.725
Market Cap: 11,719(M)
Technical analysis
2024-02-23 4:35:26 PM
Short term     
Mid term     
Targets 6-month :  99.13 1-year :  115.78
Resists First :  84.87 Second :  99.13
Pivot price 76.71
Supports First :  74.85 Second :  68.66
MAs MA(5) :  82.65 MA(20) :  75.66
MA(100) :  67.62 MA(250) :  70.29
MACD MACD :  3.1 Signal :  2
%K %D K(14,3) :  98.4 D(3) :  96.5
RSI RSI(14): 75.7
52-week High :  84.87 Low :  53.79
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BRKR ] has closed below upper band by 11.8%. Bollinger Bands are 174.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 84.98 - 85.3 85.3 - 85.63
Low: 82.85 - 83.25 83.25 - 83.65
Close: 84.03 - 84.64 84.64 - 85.24
Company Description

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Headline News

Fri, 23 Feb 2024
Bruker (NASDAQ:BRKR) Sets New 12-Month High at $84.84 - MarketBeat

Tue, 20 Feb 2024
Bruker Corp Gets IBD Stock Rating Upgrade - Investor's Business Daily

Fri, 16 Feb 2024
Bruker Announces Quarterly Dividend - Yahoo Finance

Thu, 15 Feb 2024
Bruker Corporation Revenue Breakdown – NASDAQ:BRKR – TradingView - TradingView

Thu, 15 Feb 2024
Bruker Corporation (NASDAQ:BRKR) Q4 2023 Earnings Call Transcript - Yahoo Finance

Wed, 14 Feb 2024
Bruker (BRKR) Q4 Earnings Surpass Estimates, Margins Down - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 138 (M)
Shares Float 95 (M)
Held by Insiders 34.3 (%)
Held by Institutions 80.2 (%)
Shares Short 3,720 (K)
Shares Short P.Month 3,440 (K)
Stock Financials
EPS 2.9
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 9.59
Profit Margin 14.4 %
Operating Margin 12.5 %
Return on Assets (ttm) 7 %
Return on Equity (ttm) 33.6 %
Qtrly Rev. Growth 20.6 %
Gross Profit (p.s.) 0
Sales Per Share 21.38
EBITDA (p.s.) 4.03
Qtrly Earnings Growth 112.9 %
Operating Cash Flow 350 (M)
Levered Free Cash Flow 253 (M)
Stock Valuations
PE Ratio 29.19
PEG Ratio 2
Price to Book value 8.82
Price to Sales 3.95
Price to Cash Flow 33.47
Stock Dividends
Dividend 0.05
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android